Henry Schein Q1 record sales $3.2B (+8.7% YoY), EPS $1.30 beats prior year; reaffirms FY2022 guidance

HENRY SCHEIN INC

2022-Q1 EPS reported $1.30 revenue$3,179,000,000

Net sales $3.2B, +8.7% YoY; GAAP diluted EPS $1.30 vs $1.16 YoY.
Global Dental sales $1.8B (+2.2% YoY); Global Medical $1.2B (+18.3%).
Global Technology & Value-Added Services sales $179M (+23.4%), driven by Henry Schein One.
FY2022 GAAP EPS guidance reaffirmed $4.75-$4.91 (7-10% growth); sales growth guidance narrowed to 5-8%.
$200M remaining in share repurchase authority; no shares bought in Q1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.